JX Song, JR An, Q Chen, XY Yang, CL Jia, S Xu… - …, 2022 - Taylor & Francis
Liver pathological changes are as high as 21%-78% in diabetic patients, and treatment
options are lacking. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor that is widely …